Apolipoprotein CIII is a new player in diabetes

Overview of attention for article published in Current Opinion in Lipidology, February 2017

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (69th percentile)
Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

twitter: 8 X users

Readers on

mendeley: 37 Mendeley

So far, Altmetric has seen 9 X posts from 8 X users, with an upper bound of 107,030 followers.

Article: "Apolipoprotein CIII is a new player in diabetes" is very good for $AMRN Vascepa lowers APOC3 22% https://t.co/dbDmcKWty3

study concludes Apolipoprotein CIII is a new player in diabetes. (Vascepa reduced APOCII by 22% ) $AMRN https://t.co/jSSAGNRfTJ

RT @lipiddoc: #ApoCIII in #diabetes https://t.co/0KeLR8XDun @nationallipid @ArsenaultBenoit @Drlipid @drpablocorral @NYUCVDPrevent @DrMar…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 5 additional X posts.